SG63786A1 - Compositions for the treatment of chronic wounds - Google Patents

Compositions for the treatment of chronic wounds

Info

Publication number: SG63786A1
Authority: SG; Singapore
Prior art keywords: treatment; compositions; ulcers; chronic wounds; chronic
Prior art date: 1996-12-20

Application number

SG1997004499A

Other languages

English (en)

Inventor

Stephen Bloor

Original Assignee

Johnson & Johnson Medical Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-20

Filing date

1997-12-17

Publication date

1999-03-30

1997-12-17 Application filed by Johnson & Johnson Medical Ltd filed Critical Johnson & Johnson Medical Ltd

1999-03-30 Publication of SG63786A1 publication Critical patent/SG63786A1/en

Links

238000011282 treatment Methods 0.000 title abstract 3
230000001684 chronic effect Effects 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
206010052428 Wound Diseases 0.000 title 1
208000027418 Wounds and injury Diseases 0.000 title 1
208000025865 Ulcer Diseases 0.000 abstract 2
231100000397 ulcer Toxicity 0.000 abstract 2
206010056340 Diabetic ulcer Diseases 0.000 abstract 1
PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 abstract 1
208000000558 Varicose Ulcer Diseases 0.000 abstract 1
229960004308 acetylcysteine Drugs 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

SG1997004499A 1996-12-20 1997-12-17 Compositions for the treatment of chronic wounds SG63786A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB9626468A GB2320431B (en)	1996-12-20	1996-12-20	Compositions for the treatment of chronic wounds

Publications (1)

Publication Number	Publication Date
SG63786A1 true SG63786A1 (en)	1999-03-30

Family

ID=10804743

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG1997004499A SG63786A1 (en)	1996-12-20	1997-12-17	Compositions for the treatment of chronic wounds

Country Status (11)

Country	Link
US (1)	US6166084A (de)
EP (1)	EP0848951B1 (de)
JP (1)	JPH10273438A (de)
AT (1)	ATE234615T1 (de)
AU (1)	AU726545B2 (de)
CA (1)	CA2225202A1 (de)
CO (1)	CO4930267A1 (de)
DE (1)	DE69719931T2 (de)
GB (1)	GB2320431B (de)
SG (1)	SG63786A1 (de)
ZA (1)	ZA9711467B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1312088B1 (it) *	1999-04-21	2002-04-04	Altergon Sa	Cerotto per uso topico contenente eparina e diclofenac.
JP4822652B2 (ja) *	2000-11-22	2011-11-24	エンドファーマシューティカルズインコーポレイテッド	粘膜炎の治療
US6600057B2 (en)	2000-12-29	2003-07-29	Kimberly-Clark Worldwide, Inc.	Matrix metalloproteinase inhibitors
DE10121255A1 (de) *	2001-04-30	2002-11-07	Switch Biotech Ag	Verwendung von alpha 1-Antichymotrypsin Polypeptiden oder diese kodierende Nukleinsäuren, oder einer ein ACT Polypeptid oder diese kodierende Nukleinsäure exprimierende Zelle, zur Behandlung und/oder Prävention von diabetes-assoziierten und/oder arteriellen schlecht heilenden Wunden und zur Identifizierung von pharmakologisch aktiven Substanzen
EP1425027A4 (de) *	2001-08-16	2008-02-13	Thomas M Hnat	Verfahren und zusammensetzung zur behandlung von wunden und verbrennungen
SE522979C2 (sv) *	2002-07-03	2004-03-23	Moelnlycke Health Care Ab	Sårförband innefattande en icke-enzymatisk antioxidant
CA2529236A1 (en) *	2004-12-07	2006-06-07	Centre Des Technologies Textiles	New antimicrobial material
WO2007137000A2 (en) *	2006-05-16	2007-11-29	The Arizona Board Of Regents On Behalf Of The University Of Arizona	Combination cancer chemotherapy
US20090131303A1 (en) *	2007-11-16	2009-05-21	Bor-Shyue Hong	Methods and compositions for treating dry eye
US20090177133A1 (en) *	2008-01-04	2009-07-09	Kristine Kieswetter	Reduced pressure dressing coated with biomolecules
US20100022652A1 (en) *	2008-07-28	2010-01-28	Tyco Healthcare Group Lp	Antimicrobial and Anticoagulant Compositions and Methods
GB2470040A (en) *	2009-05-06	2010-11-10	Systagenix Wound Man Ip Co Bv	Wound dressing material comprising N-acetyl cysteine
WO2010151778A2 (en) *	2009-06-25	2010-12-29	Darlene Mccord	Topical compositions and methods for wound care
US8632512B2 (en)	2010-04-09	2014-01-21	Kci Licensing, Inc.	Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
US9999702B2 (en)	2010-04-09	2018-06-19	Kci Licensing Inc.	Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
EP2397125A1 (de)	2010-06-15	2011-12-21	Histocell, S.L.	Antioxidationszusammensetzung
JP6124791B2 (ja)	2010-09-22	2017-05-10	ザリージェンツオブザユニバーシティオブコロラド，アボディーコーポレイトＴＨＥＲＥＧＥＮＴＳＯＦＴＨＥＵＮＩＶＥＲＳＩＴＹＯＦＣＯＬＯＲＡＤＯ，ａｂｏｄｙｃｏｒｐｏｒａｔｅ	Ｓｍａｄ７の治療的適用
US8597264B2 (en)	2011-03-24	2013-12-03	Kci Licensing, Inc.	Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
US9422352B2 (en) *	2013-03-08	2016-08-23	The Regents Of The University Of Colorado, A Body Corporate	PTD-SMAD7 therapeutics
EP2976095B1 (de)	2013-03-15	2020-12-23	3M Innovative Properties Company	Zusammensetzungen zur wundheilung
JP6521995B2 (ja)	2014-02-20	2019-05-29	ユニヴァーシティーオブノートルダムデュラック	選択的マトリックスメタロプロテイナーゼ阻害剤
WO2016044844A1 (en)	2014-09-19	2016-03-24	University Of Notre Dame Du Lac	Acceleration of diabetic wound healing
CA2962954A1 (en)	2014-10-14	2016-04-21	Samuel Lynch	Compositions for treating wounds
US10299503B2 (en) *	2017-01-24	2019-05-28	Recommended By Mom Llc	N-acetyl cysteine based compositions
US10292998B1 (en)	2018-08-07	2019-05-21	Ahad Mahootchi	Compositions and methods for prevention and treatment of eye infections
KR20220092493A (ko)	2019-09-06	2022-07-01	콘세호 나시오날 데 인베스티가시오네스 시엔티피카스 이 테크니카스 (코니셋)	국소 상처 치료용 약학적 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1154914A (en) *	1965-08-26	1969-06-11	Mead Johnson & Co	Anti-Inflammatory Compositions and methods
ZA702518B (en) *	1969-04-18	1971-01-27	Bristol Myers Co	Acetylcysteine for acne
US3749770A (en) *	1969-08-11	1973-07-31	Mead Johnson & Co	Compositions containing zinc mercaptide n-acetylcysteine carboxylate salts
US4276284A (en) *	1971-07-26	1981-06-30	Brown Stuart I	Prevention of collagenase induced disease by treatment with collagenase inhibitors
FR2519988B1 (fr) *	1982-01-20	1985-06-14	Refarmed Sa	Derives thioliques de l'erythromycine a activite therapeutique, procede de preparation et produits pharmaceutiques dans lesquels ils apparaissent
IT1194117B (it) *	1981-11-20	1988-09-14	Isnardi Pietro & C Spa	Derivati salicilici di n-acetilcisteina
US4414387A (en) *	1982-05-13	1983-11-08	Renato Broggi	Cephapirin acetylcysteinate having antibacterial activity
GB8517301D0 (en) *	1985-07-09	1985-08-14	Salim A S M	Synergistic biologically active substances
US4708965A (en) *	1985-09-16	1987-11-24	Morgan Lee R	Method of treating herpes virus infections with N,N'-diacetylcystine and derivatives
US4724239A (en) *	1985-09-16	1988-02-09	Morgan Lee R	Method of treating chemical ulcers with N,N'-diacetylcystine, N-acetyl homocysteine and N-acetyl cysteine
IL95393A0 (en) *	1989-08-18	1991-06-30	John Morris Co	Odor-masked and stabilized compositions for treating keratinous tissue,skin conditions,and promoting wound healing
CA2164955A1 (en) *	1993-06-18	1995-01-05	Richard J. Sharpe	Method for treating hyperkeratosis and diseases mediated by proteases
DE4328871A1 (de) *	1993-08-27	1995-03-02	Beiersdorf Ag	Mittel gegen empfindliche, hyperreaktive Hautzustände, atopische Dermatiden, Pruritus, Psoriasis Prurigo, Photodermatosen und Ichthyosis

1996
- 1996-12-20 GB GB9626468A patent/GB2320431B/en not_active Expired - Lifetime
1997
- 1997-12-15 AU AU48383/97A patent/AU726545B2/en not_active Ceased
- 1997-12-17 US US08/992,649 patent/US6166084A/en not_active Expired - Lifetime
- 1997-12-17 SG SG1997004499A patent/SG63786A1/en unknown
- 1997-12-18 CA CA002225202A patent/CA2225202A1/en not_active Abandoned
- 1997-12-19 EP EP97310391A patent/EP0848951B1/de not_active Expired - Lifetime
- 1997-12-19 ZA ZA9711467A patent/ZA9711467B/xx unknown
- 1997-12-19 AT AT97310391T patent/ATE234615T1/de not_active IP Right Cessation
- 1997-12-19 DE DE69719931T patent/DE69719931T2/de not_active Expired - Lifetime
- 1997-12-19 JP JP9365307A patent/JPH10273438A/ja active Pending
- 1997-12-22 CO CO97074402A patent/CO4930267A1/es unknown

Also Published As

Publication number	Publication date
CO4930267A1 (es)	2000-06-27
GB2320431A8 (en)	1998-12-18
CA2225202A1 (en)	1998-06-20
EP0848951A1 (de)	1998-06-24
GB2320431B (en)	2000-08-30
US6166084A (en)	2000-12-26
JPH10273438A (ja)	1998-10-13
EP0848951B1 (de)	2003-03-19
AU726545B2 (en)	2000-11-09
ZA9711467B (en)	1999-09-20
DE69719931T2 (de)	2003-12-24
GB9626468D0 (en)	1997-02-05
ATE234615T1 (de)	2003-04-15
GB2320431A (en)	1998-06-24
AU4838397A (en)	1998-06-25
DE69719931D1 (de)	2003-04-24

Publication	Publication Date	Title
GB2320431B (en)	2000-08-30	Compositions for the treatment of chronic wounds
AU5669198A (en)	1998-07-17	Cyclosporin derivative, its preparation and pharmaceutical compositions containing same
ZA954548B (en)	1996-03-15	Monoamine diamide thiol-containing metal chelating agents
AU7535798A (en)	1998-11-24	Novel cyclosporin derivatives, preparation and pharmaceutical compositions containing same
AU2001258230A1 (en)	2001-11-20	Pharmaceutical composition comprising a factor viia and a tfpi inhibitor
MY140488A (en)	2009-12-31	Substituted oxazolidinones and their use in the field of blood coagulation
ATE153853T1 (de)	1997-06-15	Stabile, orale und absorbierbare therapeutische zusammensetzungen von nadh und nadph
CA2019974A1 (en)	1991-06-04	Treatment of inflammation
PL343375A1 (en)	2001-08-13	Matrix protein compositions for wound healing
ZA896149B (en)	1990-04-25	Pharmaceutical formulation for the treatment of diabetes mellitus
ES2160643T3 (es)	2001-11-16	Composiciones que contienen g-csf y proteina de union al tnf.
AU1430492A (en)	1992-11-17	Pharmaceutical composition for the treatment of gastritis
IL126235A (en)	2003-02-12	Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
AU5917390A (en)	1991-03-14	Pharmaceutical composition for topic use for the therapeutical treatment of capillary fragility
NO983177L (no)	1998-07-10	Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
ITRM910730A1 (it)	1993-03-30	Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
ES2093357T3 (es)	1996-12-16	Metodo de tratamiento de la alopecia.
AU640687B2 (en)	1993-09-02	Antimicrobial compositions
DK0458589T3 (da)	1995-04-03	Behandling af okulær hypertension med en okulær synergistisk kombination
AU3263795A (en)	1996-03-14	Medicament for treatment or prophylaxis of incontinence
DK1100824T3 (da)	2011-06-20	Forbindelser med væksthormonfrigivende egenskaber
AU3600199A (en)	1999-10-11	A pharmaceutical composition containing ezrin mutated on tyrosine 353
TW330933B (en)	1998-05-01	Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
AU1506692A (en)	1992-10-29	Pharmaceutical compositions
DK0495226T3 (da)	1995-11-27	Anvendelse af 3-aryl-5-alkylthio-4H-1,2,4-triazoler til behandling af hyperrefleksi som følge af spinaltrauma